The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype
Abstract
Voltage-gated potassium channel complex antibodies, particularly those directed against leucine-rich glioma inactivated 1, are associated with a common form of limbic encephalitis that presents with cognitive impairment and seizures. Faciobrachial dystonic seizures have recently been reported as immunotherapy-responsive, brief, frequent events that often predate the cognitive impairment associated with this limbic encephalitis. However, these observations were made from a retrospective study without serial cognitive assessments. Here, we undertook the first prospective study of faciobrachial dystonic seizures with serial assessments of seizure frequencies, cognition and antibodies in 10 cases identified over 20 months. We hypothesized that (i) faciobrachial dystonic seizures would show a differential response to anti-epileptic drugs and immunotherapy; and that (ii) effective treatment of faciobrachial dystonic seizures would accelerate recovery and prevent the development of cognitive impairment. The 10 cases expand both the known age at onset (28 to 92 years, median 68) and clinical features, with events of longer duration, simultaneously bilateral events, prominent automatisms, sensory aura, and post-ictal fear and speech arrest. Ictal epileptiform electroencephalographic changes were present in three cases. All 10 cases were positive for voltage-gated potassium channel-complex antibodies (346-4515 pM): nine showed specificity for leucine-rich glioma inactivated 1. Seven cases had normal clinical magnetic resonance imaging, and the cerebrospinal fluid examination was unremarkable in all seven tested. Faciobrachial dystonic seizures were controlled more effectively with immunotherapy than anti-epileptic drugs (P = 0.006). Strikingly, in the nine cases who remained anti-epileptic drug refractory for a median of 30 days (range 11-200), the addition of corticosteroids was associated with cessation of faciobrachial dystonic seizures within 1 week in three and within 2 months in six cases. Voltage-gated potassium channel-complex antibodies persisted in the four cases with relapses of faciobrachial dystonic seizures during corticosteroid withdrawal. Time to recovery of baseline function was positively correlated with time to immunotherapy (r = 0.74; P = 0.03) but not time to anti-epileptic drug administration (r = 0.55; P = 0.10). Of 10 cases, the eight cases who received anti-epileptic drugs (n = 3) or no treatment (n = 5) all developed cognitive impairment. By contrast, the two who did not develop cognitive impairment received immunotherapy to treat their faciobrachial dystonic seizures (P = 0.02). In eight cases without clinical magnetic resonance imaging evidence of hippocampal signal change, cross-sectional volumetric magnetic resonance imaging post-recovery, after accounting for age and head size, revealed cases (n = 8) had smaller brain volumes than healthy controls (n = 13) (P < 0.001). In conclusion, faciobrachial dystonic seizures can be prospectively identified as a form of epilepsy with an expanding phenotype. Immunotherapy is associated with excellent control of the frequently anti-epileptic drug refractory seizures, hastens time to recovery, and may prevent the subsequent development of cognitive impairment observed in this study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A nonparametric method for automatic correction of intensity nonuniformity in MRI data
Sled, J. G., Zijdenbos, A. P., & Evans, A. C. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.668698 · Cited by 4,731 · cited 1×
“Images were corrected for intensity inhomogeneity using the N3 algorithm (Sled et al., 1998).”
MethodAnti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
Mioshi, E., Dawson, K., Mitchell, J., Arnold, R., & Hodges, J. R. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1610 · Cited by 2,016
Recommended diagnostic criteria for paraneoplastic neurological syndromes
Graus, F. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.034447 · Cited by 1,610
Alzheimer’s Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2007) · Advances in Behavioral Biology · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,468
Lai, M., Huijbers, M. G., Lancaster, E., Graus, F., Bataller, L., Balice-Gordon, R., Cowell, J. K., & Dalmau, J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70137-x · Cited by 1,361
Irani, S. R., Alexander, S., Waters, P., Kleopa, K. A., Pettingill, P., Zuliani, L., Peles, E., Buckley, C., Lang, B., & Vincent, A. (2010) · Brain · doi:10.1093/brain/awq213 · Cited by 1,359
Self-citationVincent, A., Buckley, C., Schott, J. M., Baker, I., Dewar, B., Detert, N., Clover, L., Parkinson, A., Bien, C. G., Omer, S., et al. (2004) · Brain · doi:10.1093/brain/awh077 · Cited by 1,038
Self-citationIrani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
Self-citationFaciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis
Irani, S. R., Michell, A. W., Lang, B., Pettingill, P., Waters, P., Johnson, M. R., Schott, J. M., Armstrong, R. J. E., S. Zagami, A., Bleasel, A., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22307 · Cited by 928
Self-citationImmunopathology of autoantibody-associated encephalitides: clues for pathogenesis
Bien, C. G., Vincent, A., Barnett, M. H., Becker, A. J., Blumcke, I., Graus, F., Jellinger, K. A., Reuss, D. E., Ribalta, T., Schlegel, J., et al. (2012) · Brain · doi:10.1093/brain/aws082 · Cited by 695
Self-citationDeletion of the KV1.1 Potassium Channel Causes Epilepsy in Mice
Smart, S. L., Lopantsev, V., Zhang, C. L., Robbins, C. A., Wang, H., Chiu, S. Y., Schwartzkroin, P. A., Messing, A., & Tempel, B. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)81018-1 · Cited by 599
Brain morphometry with multiecho MPRAGE
van der Kouwe, A. J. W., Benner, T., Salat, D. H., & Fischl, B. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.12.025 · Cited by 596
Autoantibodies associated with diseases of the CNS: new developments and future challenges
Vincent, A., Bien, C. G., Irani, S. R., & Waters, P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70096-5 · Cited by 542
Self-citationMorvan syndrome: Clinical and serological observations in 29 cases
Irani, S. R., Pettingill, P., Kleopa, K. A., Schiza, N., Waters, P., Mazia, C., Zuliani, L., Watanabe, O., Lang, B., Buckley, C., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23577 · Cited by 540
Self-citationPotassium channel antibodies in two patients with reversible limbic encephalitis
Buckley, C., Oger, J., Clover, L., Tüzün, E., Carpenter, K., Jackson, M., & Vincent, A. (2001) · Annals of Neurology · doi:10.1002/ana.1097 · Cited by 444
Self-citationLiguori, R. (2001) · Brain · doi:10.1093/brain/124.12.2417 · Cited by 407
Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody
Thieben, M. J., Lennon, V. A., Boeve, B. F., Aksamit, A. J., Keegan, M., & Vernino, S. (2004) · Neurology · doi:10.1212/01.wnl.0000122648.19196.02 · Cited by 394
Autoimmune Epilepsy: Clinical Characteristics and Response to Immunotherapy
Quek, A. M. L. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2985 · Cited by 359
Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy
Morante-Redolat, J. M. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1119 · Cited by 344
Schulte, U., Thumfart, J.-O., Klöcker, N., Sailer, C. A., Bildl, W., Biniossek, M., Dehn, D., Deller, T., Eble, S., Abbass, K., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.033 · Cited by 321
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia
Hart, I. K., Waters, C., Vincent, A., Newland, C., Beeson, D., Pongs, O., Morris, C., & Newsom‐Davis, J. (1997) · Annals of Neurology · doi:10.1002/ana.410410215 · Cited by 315
Self-citationZuliani, L., Graus, F., Giometto, B., Bien, C., & Vincent, A. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301237 · Cited by 293
Self-citationClinical spectrum of voltage-gated potassium channel autoimmunity
Tan, K. M., Lennon, V. A., Klein, C. J., Boeve, B. F., & Pittock, S. J. (2008) · Neurology · doi:10.1212/01.wnl.0000312275.04260.a0 · Cited by 281
Jorge Cardoso, M., Leung, K., Modat, M., Keihaninejad, S., Cash, D., Barnes, J., Fox, N. C., & Ourselin, S. (2013) · Medical Image Analysis · doi:10.1016/j.media.2013.02.006 · Cited by 245
Self-citationLimbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy
Bien, C. G., Urbach, H., Schramm, J., Soeder, B. M., Becker, A. J., Voltz, R., Vincent, A., & Elger, C. E. (2007) · Neurology · doi:10.1212/01.wnl.0000276946.08412.ef · Cited by 235
Self-citationVoltage-Gated Potassium Channel Autoimmunity Mimicking Creutzfeldt-Jakob Disease
Geschwind, M. D., Tan, K. M., Lennon, V. A., Barajas, R. F., Haman, A., Klein, C. J., Josephson, S. A., & Pittock, S. J. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1341 · Cited by 193
Chronic pain as a manifestation of potassium channel-complex autoimmunity
Klein, C. J., Lennon, V. A., Aston, P. A., McKeon, A., & Pittock, S. J. (2012) · Neurology · doi:10.1212/wnl.0b013e3182698cab · Cited by 185
Brain MAPS: An automated, accurate and robust brain extraction technique using a template library
Leung, K. K., Barnes, J., Modat, M., Ridgway, G. R., Bartlett, J. W., Fox, N. C., & Ourselin, S. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.12.067 · Cited by 182
Tonic seizures: A diagnostic clue of anti-LGI1 encephalitis?
Andrade, D. M., Tai, P. C., Dalmau, J. O., & Wennberg, R. A. (2011) · Neurology · doi:10.1212/wnl.0b013e3182152808 · Cited by 149
Chabrol, E., Navarro, V., Provenzano, G., Cohen, I., Dinocourt, C., Rivaud-Péchoux, S., Fricker, D., Baulac, M., Miles, R., Leguern, É., et al. (2010) · Brain · doi:10.1093/brain/awq171 · Cited by 142
IMMUNOTHERAPY-RESPONSIVE SEIZURE-LIKE EPISODES WITH POTASSIUM CHANNEL ANTIBODIES
Irani, S. R., Buckley, C. J., Vincent, A. C., Cockerell, O. C., Rudge, P., Johnson, M. R., & Smith, S. J. M. (2008) · Neurology · doi:10.1212/01.wnl.0000326572.93762.51 · Cited by 141
Self-citationLalic, T., Pettingill, P., Vincent, A. C., & Capogna, M. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02756.x · Cited by 126
Self-citationContactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia
Becker, E. B. E., Zuliani, L., Pettingill, R., Lang, B., Waters, P. J., Dulneva, A., Sobott, F., Wardle, M., Graus, F., Bataller, L., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301506 · Cited by 117
Self-citationChan, D., Henley, S. M. D., Rossor, M. N., & Warrington, E. K. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.404 · Cited by 56
Kashiwamura, Y., Sano, Y., Abe, M., Shimizu, F., Haruki, H., Maeda, T., Kawai, M., & Kanda, T. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0413-6 · Cited by 54
Amnesia, cerebral atrophy, and autoimmunity
Schott, J. M., Harkness, K. A., Barnes, J., della Rocchetta, A. I., Vincent, A. C., & Rossor, M. N. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12983-2 · Cited by 50
Self-citation
Cited by
Antibody-Mediated Encephalitis
Dalmau, J., & Graus, F. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1708712 · Cited by 1,329
Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
Dubey, D., Pittock, S. J., Kelly, C. R., McKeon, A., Lopez‐Chiriboga, A. S., Lennon, V. A., Gadoth, A., Smith, C. Y., Bryant, S. C., Klein, C. J., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25131 · Cited by 777
Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up
van Sonderen, A., Thijs, R. D., Coenders, E. C., Jiskoot, L. C., Sanchez, E., de Bruijn, M. A. A. M., van Coevorden-Hameete, M. H., Wirtz, P. W., Schreurs, M. W. J., Sillevis Smitt, P. A. E., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003173 · Cited by 658
Dalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
The Diagnosis and Treatment of Autoimmune Encephalitis
Lancaster, E. (2016) · Journal of Clinical Neurology · doi:10.3988/jcn.2016.12.1.1 · Cited by 437
Metadata
- Authors
- Irani, S. R., Stagg, C. J., Schott, J. M., Rosenthal, C. R., Schneider, S. A., Pettingill, P., Pettingill, R., Waters, P., Thomas, A., Voets, N. L., Cardoso, M. J., Cash, D. M., Manning, E. N., Lang, B., Smith, S. J. M., Vincent, A., & Johnson, M. R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-09-06
- Volume
- 136
- Issue
- 10
- Pages
- 3151-3162
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2090105299
- Cited by
- 437
- References
- 37
- FWCI
- 22.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.